Institutional Ownership Provectus Biopharmaceuticals, Inc. (PVCT)
This table provides information about the institutional ownership of Provectus Biopharmaceuticals, Inc. (PVCT). We have compiled data on the 7 institutions that hold shares in the stock, with a total of 226,812 shares, which have been reported (via 13F filing form) to have a value of $27,000.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Home Federal Bank Of Tennessee
|
Oct 21, 2024 Q3 2024 |
100,000
shares
|
$12,000
0.0% of portfolio
|
Q3 2017
New holding
|
|
|
Lee Danner & Bass Inc
|
Oct 30, 2024 Q3 2024 |
50,000
shares
|
$6,000
0.0% of portfolio
|
Q2 2020
New holding
|
|
|
Atlas Wealth LLC
Cincinnati, OH |
Nov 14, 2024 Q3 2024 |
26,620
shares
|
$3,194
0.0% of portfolio
|
Q4 2022
New holding
|
|
|
Lbmc Investment Advisors, LLC
|
Oct 08, 2024 Q3 2024 |
20,000
shares
|
$2,400
0.0% of portfolio
|
Q3 2024
Reduced 9.09%
|
|
|
Academy Capital Management Inc
Waco, TX |
Oct 17, 2024 Q3 2024 |
20,000
shares
|
$2,400
0.0% of portfolio
|
Q4 2023
New holding
|
|
|
Financial Symmetry Inc
Raleigh, NC |
Oct 21, 2024 Q3 2024 |
10,191
shares
|
$1,222
0.0% of portfolio
|
Q4 2023
New holding
|
|
|
Huntington National Bank
Columbus, OH |
Nov 06, 2024 Q3 2024 |
1
shares
|
$0
0.0% of portfolio
|
Q2 2019
New holding
|